AstraZeneca Pharma shares rose after the company received regulatory approval to expand the use of its cancer drug Imfinzi ...

Although headquartered in the UK, AstraZeneca is still known as the 'Anglo-Swedish pharma company', having been created from the merger of the British Zeneca and Sweden's Astra in 1999.

FRANKFURT: European shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

EUROPEAN shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

The Dow Jones Industrial Average rose sharply on Tuesday (July 1), gaining 401 points or 0.9%, as investors rotated out of ...

European shares fell on Tuesday on the back of poor performances from the banking and defence sectors, as uncertainty ...

From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in ...

By Sukriti Gupta, Sanchayaita Roy and Shashwat Chauhan (Reuters) -European shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed uncertainty over U.

There are great global stocks we can buy other than US shares. The post Worried about US shares? I'd look at buying these two ...

Solana underwhelms in H1, but this week's key positive developments (ETFs and tokenized stocks) could set the tone for H2.